Drug Design: Structure- and Ligand-Based Approaches
★★★★★
★★★★★
English
Structure-based (SBDD) and ligand-based (LBDD) drug design are extremely important and active areas of research in both the academic and commercial realms. This book provides a complete snapshot of the field of computer-aided drug design and associated experimental approaches. Topics covered include X-ray crystallography, NMR, fragment-based drug design, free energy methods, docking and scoring, linear-scaling quantum calculations, QSAR, pharmacophore methods, computational ADME-Tox, and drug discovery case studies. A variety of authors from academic and commercial institutions all over the world have contributed to this book, which is illustrated with more than 200 images. This is the only book to cover the subject of structure and ligand-based drug design, and it provides the most up-to-date information on a wide range of topics for the practising computational chemist, medicinal chemist, or structural biologist. Professor Kenneth Merz has been selected as the recipient of the 2010 ACS Award for Computers in Chemical & Pharmaceutical Research that recognizes the advances he has made in the use of quantum mechanics to solve biological and drug discovery problems.
See more
Current price
€117.79
Original price
€123.99
Save 5%
Will deliver when available.
Product Details
Weight: 1210g
Dimensions: 225 x 285mm
Publication Date: 31 May 2010
Publisher: Cambridge University Press
Publication City/Country: United Kingdom
Language: English
ISBN13: 9780521887236
About
Kenneth M. Merz received his PhD in organic chemistry at the University of Texas at Austin and completed postdoctoral research at Cornell University and the University of California San Francisco. He is a member of the Quantum Theory Project and Professor of Chemistry at the University of Florida Gainesville. Dagmar Ringe received her PhD in biochemistry at Boston University. She is Professor of Biochemistry and Chemistry in the Rosenstiel Basic Medical Sciences Research Center at Brandeis University Waltham Massachusetts. Charles H. Reynolds received his PhD in theoretical organic chemistry at the University of Texas Austin. He is a Research Fellow at Johnson & Johnson Pharmaceutical Research and Development Spring House Pennsylvania.